📣 VC round data is live. Check it out!
- Public Comps
- MediClin
MediClin Valuation Multiples
Discover MediClin's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Goodwill Pharma, Monash IVF Group, Clinica Las Condes, Athens Medical Centre and more.
MediClin Overview
About MediClin
MediClin AG operates hospitals and other medical care centers. The company's reportable operating segments are the Post-acute, Acute, Nursing care, and Service segments. A majority of its revenue is generated from the Post-acute segment, which offers services in the fields of follow-up rehabilitation treatment and curative treatment. Some of the post-acute hospitals also offer services in acute neurology and acute psychosomatics. The Acute segment encompasses medical offerings with a focus on neurology and neurological early rehabilitation as well as psychosomatic medicine, psychiatry, orthopaedics, and internal medicine. The Nursing care segment offers full-time and part-time nursing care as well as daycare, and the Service segment consists of the central services.
Founded
1996
HQ

Employees
9.8K
Website
Sectors
Financials (LTM)
EV
$460M
Valuation Multiples
Start free trialMediClin Financials
MediClin reported last 12-month revenue of $917M and EBITDA of $131M.
In the same LTM period, MediClin generated $131M in EBITDA and $35M in net income.
Revenue (LTM)
MediClin P&L
In the most recent fiscal year, MediClin reported revenue of $872M and EBITDA of $124M.
MediClin is profitable as of last fiscal year, with gross margin of 83%, EBITDA margin of 14%, and net margin of 3%.
Financial data powered by Morningstar, Inc.
MediClin Stock Performance
MediClin has current market cap of $207M, and enterprise value of $460M.
Market Cap Evolution
MediClin's stock price is $4.36.
MediClin share price decreased by 0.1% in the last 30 days, and increased by 25.8% in the last year.
MediClin has an EPS (earnings per share) of $0.61.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $460M | $207M | -0.1% | -0.1% | 9.1% | 25.8% | $0.61 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialMediClin Valuation Multiples
MediClin trades at 0.5x EV/Revenue multiple, and 3.5x EV/EBITDA.
EV / Revenue (LTM)
MediClin Financial Valuation Multiples
As of June 2, 2026, MediClin has market cap of $207M and EV of $460M.
MediClin has a P/E ratio of 5.9x.
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified MediClin Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


MediClin Margins & Growth Rates
MediClin grew revenue by 4% and EBITDA by 4% in the last fiscal year.
In the most recent fiscal year, MediClin reported gross margin of 83%, EBITDA margin of 14%, and net margin of 3%.
MediClin Margins
MediClin Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
MediClin Operational KPIs
MediClin's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
MediClin's Rule of 40 is 18% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
MediClin's Rule of X is 23% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
MediClin Competitors
MediClin competitors include Goodwill Pharma, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED and Humana.
Most MediClin public comparables operate across Hospitals & Clinics.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 3.0x | - | 11.2x | - | |||
| 1.7x | 1.8x | 7.4x | 8.0x | |||
| 2.7x | - | (5.9x) | - | |||
| 1.1x | - | 11.0x | - | |||
| 2.8x | 2.7x | 19.4x | 17.6x | |||
| 2.7x | 2.5x | 10.9x | 9.6x | |||
| 5.1x | 5.3x | 15.9x | 17.0x | |||
| 9.1x | 7.6x | (3.5x) | (3.7x) | |||
This data is available for Pro users. Sign up to see all MediClin competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by MediClin
MediClin has acquired 1 company to date.
Last acquisition by MediClin was on March 22nd 2024. MediClin acquired Reha-Klinik am Sendesaal for undisclosed valuation.
Latest Acquisitions by MediClin
| Description | Reha-Klinik am Sendesaal is a Duisburg-based interdisciplinary rehabilitation clinic in Germany providing inpatient and outpatient programs in cardiology, orthopedics, and geriatrics. The 120-bed facility offers post-acute care with physiotherapy, occupational therapy, and hydrotherapy in the Rhine-Ruhr region. |
| HQ Country | |
| HQ City | Bremen |
| Deal Date | 22 Mar 2024 |
| Valuation | undisclosed |
| EV/Revenue | |
| EV/EBITDA | |
This data is available for Pro users. Sign up to see all MediClin acquisitions and their M&A valuation multiples. Start Free Trial | |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout MediClin
| When was MediClin founded? | MediClin was founded in 1996. |
| Where is MediClin headquartered? | MediClin is headquartered in Germany. |
| How many employees does MediClin have? | As of today, MediClin has over 9K employees. |
| Is MediClin publicly listed? | Yes, MediClin is a public company listed on Frankfurt Stock Exchange. |
| What is the stock symbol of MediClin? | MediClin trades under MED ticker. |
| When did MediClin go public? | MediClin went public in 2000. |
| Who are competitors of MediClin? | MediClin main competitors include Goodwill Pharma, Monash IVF Group, Clinica Las Condes, Athens Medical Centre, Atrys Health, Limes Schlosskliniken, Suraksha Diagnostics, Hyperfine, Centrum Medyczne ENEL-MED, Humana. |
| What is the current market cap of MediClin? | MediClin's current market cap is $207M. |
| What is the current revenue of MediClin? | MediClin's last 12 months revenue is $917M. |
| What is the current revenue growth of MediClin? | MediClin revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of MediClin? | Current revenue multiple of MediClin is 0.5x. |
| What is the current EBITDA of MediClin? | MediClin's last 12 months EBITDA is $131M. |
| What is MediClin's EBITDA margin? | MediClin's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of MediClin? | Current EBITDA multiple of MediClin is 3.5x. |
| What is the current FCF of MediClin? | MediClin's last 12 months FCF is $71M. |
| What is MediClin's FCF margin? | MediClin's last 12 months FCF margin is 8%. |
| What is the current EV/FCF multiple of MediClin? | Current FCF multiple of MediClin is 6.5x. |
| How many companies MediClin has acquired to date? | As of June 2026, MediClin has acquired 1 company. |
| What was the largest acquisition by MediClin? | None of the M&A deals MediClin has completed have disclosed valuations. |
| In how many companies MediClin has invested to date? | MediClin hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to MediClin
Lists including MediClin
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.
